Jorge Manchola, a retired Air Force staff sergeant, was diagnosed with stage 4 lung cancer in 2023. The cancer had spread to ...

Mutations in the tumor suppressor TP53 are a common cause of cancer, making the altered protein an attractive target for ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...

A newly identified and rare genetic variant slows the growth of mutated blood stem cells and reduces the risk of leukemia.

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited ...

One in 6 patients with colorectal cancer have an inherited cancer-related gene mutation which likely predisposed them to the disease, according to a Mayo Clinic study. About 16 percent of the 361 ...

Cancer survival rates climbed significantly in recent decades. But federal funding cuts could threaten that progress, ...